Today on THCB Spotlights, Matthew speaks with Jeremy Orr, CEO of Medial EarlySign. Medial EarlySign does complex algorithmic detection of serious diseases, working on early detection of cancer and the progression of chronic disease such as diabetes. Tune in to hear more about this AI/ML company that has been working on their algorithms since before many had even heard about machine learning, what they’ve been doing with Kaiser Permanente and Geisinger, and where they are going next.
Filmed at the HLTH Conference in Las Vegas, October 2019.
The post THCB Spotlights: Jeremy Orr, CEO of Medial EarlySign appeared first on The Health Care Blog.